From February 7, 2024 to February 27, 2024, the company has repurchased 2,739,026 shares, representing 1.89% for CNY 50 million. With this, the company has completed the repurchase of 2,739,026 shares, representing 1.89% for CNY 50 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.54 CNY | -0.62% | -1.36% | -42.69% |
1st Jan change | Capi. | |
---|---|---|
-42.69% | 284M | |
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 300878 Stock
- News Zhejiang Wecome Pharmaceutical Company Limited
- Tranche Update on Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback Plan announced on February 7, 2024.